Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 2, 2000, Pages 266-270

  Sokhna, Cheikh Sadibou ^a   Rogier, Christophe ^b,c   Dieye, Alioune ^b   Trape, Jean François ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUINIMAX; QUININE;

ADOLESCENT; ARTICLE; CHILD; DISEASE TRANSMISSION; FEMALE; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; RECURRENT DISEASE; REINFECTION;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034055892     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.266     Document Type: Article

References (20)

1. Hoffman SL, Oster CN, Plowe CV, Woollett GR, Beier JC, Chulay JD, Wirth RA, Hollingdale MR, Mugambi M, 1987. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 237: 1639-1642.
2. Dieye A, Rogier C, Trape JF, Sarthou JL, Druilhe P, 1997. HLA class I-associated resistance to severe malaria: a parasitological re-assessment. Parasitol Today 13: 48-49.
3. McElroy PD, Beier JC, Oster CN, Beadle C, Sherwood JA, Oloo AJ, Hoffman SL, 1994. Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg 51: 523-532.
4. Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, Perkins PV, Chumo DK, Kocch DV, Whitmire RE, Roberts CR, Diggs CL, Hoffman SL, 1994. Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 51: 529-536.
5. Beadle C, McElroy PD, Oster CN, Beier JC, Oloo AJ, Onyango FK, Chumo DK, Bales JD, Sherwood JA, Hoffman SL, 1995. Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis 172: 1047-1054.
6. McElroy PD, Beier JC, Onyango FK, Oloo AJ, Beadle C, Hoffman SL, 1997. Dose and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in western Kenya. Am J Epidemiol 145: 945-956.
7. WHO, 1997. Guidelines for the Evaluation of Plasmodium falciparum Vaccines in Populations Exposed to Natural Infection. Geneva: World Health Organization. TDR/MAL/VAC/ 97.
8. Trape JF, Rogier C, Konaté L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Druilhe P, Pereira da Silva L, 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
9. Rogier C, Ly AB, Tall A, Cissé B, Trape JF, 1999. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg 60: 410-420.
10. Trape JF, Peelman P, Morault-Peelman B, 1985. Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission. Trans R Soc Trop Med Hyg 79: 435-442.
11. Rogier C, Commenges D, Trape JF, 1996. Evidence for an agedependent pyrogenic threshold of malaria parasitemia in individuals continuously exposed to Plasmodium falciparum. Am J Trop Med Hyg 54: 613-619.
12. Konaté L, Diagne N, Brahimi K, Faye O, Legros F, Rogier C, Petrarca V, Trape JF, 1994. Biologie des vecteurs et transmission de Plasmodium falciparum, P. malariae et P. ovale dans un village de savane d'Afrique de l'Ouest (Dielmo, Sénégal). Parasite 1: 325-333.
13. Fontenille D, Lochouarn L, Diagne N, Sokhna CS, Lemasson JJ, Diatta M, Konate L, Faye F, Rogier C, Trape JF, 1996. High variations of malaria transmission and vector species composition in Dielmo, a holoendemic area in Senegal. Am J Trop Med Hyg 56: 247-253.
14. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC, 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am J Trop Med Hyg 58: 354-357.
15. ®) treatment of uncomplicated malaria to 3 days does not increase the recurrence of attacks among children living in a highly endemic area of Senegal. Trans R Soc Trop Med Hyg 90: 175-178.
16. Carnevale P, Frezil JL, Bosseno MF, Le Pont F, Lancien J, 1978. Etude de l'agressivité d'Anopheles gambiae A en fonction de l'âge et du sexe des sujets humains. Bull World Health Organ 56: 147-154.
17. Allison AC, 1954. Protection afforded by sickle cell trait against subtertian malarial infection. Br Med J 1: 290-294.
18. Ntoumi F, Rogier C, Dieye A, Trape JF, Millet P, Mercereau-Puijalon O, 1997. Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait. Mol Med 9: 581-592.
19. Hill AVS, Allsopp CE, Kwiatowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM, 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600.
20. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend ARM, McMichael AJ, Whittle HC, 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434-439.